Nukkleus Inc. (NUKK) Stock Soars 30% on $10M Private Placement for Israeli Defense Tech Acquisition

Nukkleus Inc. (NUKK) shares surged 29.9% premarket after announcing a $10 million private placement to fund the acquisition of Star 26 Capital Inc., which owns 95% of RIMON, an Israeli defense technology firm. RIMON supplies components for the Iron Dome and develops tactical vehicles. The placement will issue 1.66 million units at $6.00 each, closing around December 19th. This acquisition positions Nukkleus for growth in the defense technology sector.

Tenaz Energy Announces Strong Q3 2024 Results and $140 Million Note Offering, Bolstering International Growth

Tenaz Energy Corp. (TNZ) has announced robust third-quarter 2024 financial and operational results, highlighted by a successful $140 million private placement of Senior Unsecured Notes due 2029. This financing strategy further strengthens the company’s commitment to its international expansion, particularly through the acquisition of NAM Offshore B.V. (NOBV) in the Netherlands.

Decibel Cannabis Announces $3.5 Million Private Placement to Fuel Growth and AgMedica Integration

Decibel Cannabis Company Inc. (DB:DBCCF) plans to raise up to $3.5 million through a non-brokered private placement of common shares. The funds will be used for general working capital purposes and to facilitate the integration of AgMedica BioScience Inc., which Decibel recently acquired. The offering is subject to regulatory approvals and is expected to close in one or more tranches by November 30, 2024.

Quimbaya Gold Completes Private Placement, Secures $348,273.72 for Projects

Quimbaya Gold Inc. announced the successful completion of a private placement, raising $348,273.72 through the issuance of units. The funds will be used to advance the company’s gold exploration projects in Colombia and for general working capital purposes. The private placement also included participation by certain insiders of the company, and the company granted stock options to directors, officers, and consultants.

Inhibikase Therapeutics Soars 31% on $110 Million Private Placement

Inhibikase Therapeutics Inc (IKT) stock surged over 30% on Wednesday after the company announced a $110 million private placement financing. The funds will support a Phase 2b trial for pulmonary arterial hypertension (PAH) and general corporate needs. The deal involves the sale of common stock, pre-funded warrants, and accompanying Series A-1 and B-1 warrants, with new board members joining and existing ones resigning. The placement is expected to close on October 21.

SOBR Safe Inc Stock Plunges After Private Placement Announcement

SOBR Safe Inc’s stock price plummeted by over 33% on Tuesday after the company announced a private placement of stock. This move aims to raise $8.2 million for general corporate purposes and working capital. The private placement involves issuing units consisting of shares and warrants. The stock’s 52-week high and low are also noted, providing context for the recent decline.

Scroll to Top